This case series explores surgical outcomes using the aqueous aurolab drainage implant in pediatric glaucoma, indicating potential benefits for refractory cases.
Pediatric glaucoma is prevented with its early diagnosis and timely management. Nowadays, aqueous aurolab drainage implant (AADI) is preferably favored over other filtration procedures due to their positive results and frequent correlation with fewer long-term, vision-threatening problems for childhood glaucoma. AADI 250 mm² (AADI, Aurolab, Madurai, India) is a new, nonvalved, cost-effective implant based on the Baerveldt glaucoma implant design (250 mm 2 ), designed specifically for the pediatric population. We presented six cases of refractory pediatric glaucoma treated with AADI (250 mm²).
No takes yet. Share an insight, caveat, or question.
Maheshwari et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: